SAVE THE DATE
Join Dr. Cheung & Dr. Sutton LIVE as they discuss how new disease-modifying therapies are shifting FOP care away from "watchful waiting".
📅 September 30th
⏰ 12:00pm EST
🔗 https://t.co/kNuINCdBoC
#RareDisease#FOP#MedEd
CAR T-cell therapy is opening a new frontier in B cell-driven systemic lupus erythematosus. Examine the early clinical evidence, patient eligibility for clinical trials, and the rheumatologist’s role throughout the treatment journey.
▶️ https://t.co/1RgRDdjEpx
This World Systemic Sclerosis Day, increase awareness of scleroderma and its potentially life-threatening complications. Together, we can support timely diagnosis, collaborative care, and improved outcomes for patients worldwide.
▶️ https://t.co/5LDwNRdS3w
When biologics are not enough, what is next? In this CME, navigate challenging spondyloarthritis cases and strengthen your approach to assessment, treatment, and shared decision-making.
▶️ https://t.co/gqafgMziRY
Explore expert-led, evidence-based guidance on biosimilars and what primary care clinicians need to know to integrate them into evolving treatment strategies.
▶️ https://t.co/1kWCWyeLHZ
Back and joint pain can mean more than you think. In this CME, work through complex PsA and axSpA cases and refine treatment decisions when first-line therapies fall short.
▶️ https://t.co/gqafgMziRY
rExplore our latest content on biosimilars in IBD, covering key clinical evidence, safety, and best practices for effective integration into treatment pathways to improve patient outcomes.
▶️ https://t.co/1kWCWyeLHZ
Back and joint pain can mean more than you think. In this CME, work through complex PsA and axSpA cases and refine treatment decisions when first-line therapies fall short.
▶️ https://t.co/gqafgMziRY
Rely on Medscape AI for your next clinical conundrum.
Get exclusive access to your evidence-based answers and discover why HCPs like Dr. Narjust Florez trust our clinical precision.
Try it here: https://t.co/GNZY4DYv7k
#ad
Are your treatment standards up to date?
Ahead of the latest ERS guidelines, we discuss managing complex cases, from airway clearance to novel anti-inflammatory classes. Learn how to bridge the gap from research to bedside.
Catch the full stream ➡️ https://t.co/bICnKbylbj
Millions of physicians like Dr. Akua Ampadu trust Medscape globally. Now, with AI, that trusted expertise delivers fairness, accuracy, and transparency at scale.
Try it here: https://t.co/x2AGfuigYN
#ad
Imagine a future where we don't just manage the decline, but stop it.
New clinical snapshots suggest we are "nearly there." Catch up on the latest research and how it is redefining the prognosis for patients with IgAN.
Watch the full discussion ➡️ https://t.co/ifHd9k0kbE
#CME
The conversation is changing.
We are moving beyond supportive care toward a new era of true disease modification. See what the latest data means for your clinical practice and long-term patient outcomes.
Watch the full discussion ➡️ https://t.co/ifHd9k0kbE
#CME
The bronchiectasis landscape is shifting
From disrupting the "vicious vortex" to the new FDA approval of DPP-1 inhibitors, get the latest clinical guidance and real-world implementation strategies for your patients.
Watch the full discussion ➡️ https://t.co/bICnKbylbj
#CME
The "vicious vortex" drives bronchiectasis progression. Are you targeting the right pathways?
Experts break down the pathophysiology, inflammation cycles, and how new FDA-approved therapies are changing the standard of care.
Watch the full video ➡️ https://t.co/bICnKbylbj
#CME
Missed our ASN Kidney Week live stream?
Hear the expert breakdown of "really, really exciting" late-breaker data and what it means for B-cell developments in IgA nephropathy.
Watch the full video ➡️ https://t.co/SxWHzKmMwt
#CME
Is a lifetime without kidney failure finally possible?
We are closer than ever. Experts discuss the shift from merely delaying progression to potentially preventing it entirely for patients with IgAN.
Watch the full video ➡️ https://t.co/ifHd9k0kbE
#CME
Watch LIVE in 1 HOUR! ➡️ https://t.co/l4LneuyTxt
Improving patient outcomes starts with translating evidence into practice. Are you up to date on how to identify and protect patients in the early phases of bronchiectasis treatment?
#Pulmonology#Bronchiectasis#CME